Chinese company fund invests in AI specialist

13-06-2018

Chinese company fund invests in AI specialist

PhonlamaiPhoto / iStockphoto.com

China-based pharmaceutical technology company WuXi AppTec has partnered with artificial intelligence (AI) specialist Insilico Medicine to integrate Insilico’s AI technology with WuXi’s laboratory infrastructure.


Insilico Medicine, WuXi AppTec, fund, investment, artificial intelligence, technology, drug discovery, aging research

LSIPR